OpenUnited Kingdom
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins
Key facts
- Buyer
- NHS England, Leeds
- Country
- United Kingdom
- Region
- UKI45
- Estimated value
- £176.0M
- Published
- Source
- UK Find a Tender
Description
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux – CM/PHR/22/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Summary and why it fits you — in your account
Subscribers get a short summary in their language and an explanation of how the tender matches their searches.
Open in your accountOpen on the platform: UK Find a TenderLeaves this site. Terms of participation and documents are there.
Get tenders like this every day
Save a search for the category and new tenders reach your inbox or Telegram before your competitors see them. 5 days free.
Start for free
No card. Your first saved search is already set up.